Organogenesis Holdings (ORGO) Interest & Investment Income (2017 - 2019)
Organogenesis Holdings' (ORGO) quarterly Interest & Investment Income came in at $19000.0 in Q1 2019, little changed year-on-year from $19000.0 in Q1 2018, and up 280.0% quarter-over-quarter from $5000.0 in Q4 2018.
Organogenesis Holdings (ORGO) Interest & Investment Income (2017 - 2019) Analysis & Trends
Organogenesis Holdings' Interest & Investment Income history runs 3 years deep, the most recent figure standing at $19000.0 for Q1 2019.
- On a quarterly basis, Interest & Investment Income changed 0.0% year-over-year to $19000.0 in Q1 2019; TTM through Mar 2019 was $64000.0, a 41.82% decrease from a year earlier, with the FY2018 full-year figure at $64000.0, down 50.39% from the prior year.
- Interest & Investment Income rose to $19000.0 in Q1 2019 per ORGO's latest filing, from $5000.0 in the prior quarter.
- Across five years, Interest & Investment Income topped out at $38000.0 in Q1 2017 and bottomed at $5000.0 in Q4 2018.
- The 3-year median for Interest & Investment Income is $20000.0 (2018), against an average of $23555.6.
- Across the five-year window, Interest & Investment Income plunged 82.14% in 2018 and changed 0.0% in 2019, its largest moves.
- Year by year, Interest & Investment Income stood at $28000.0 in 2017, then plunged by 82.14% to $5000.0 in 2018, then soared by 280.0% to $19000.0 in 2019.
- Per Business Quant, the three latest ORGO Interest & Investment Income figures stand at $19000.0 (Q1 2019), $5000.0 (Q4 2018), and $20000.0 (Q3 2018).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 89.28 Bn | 87.42 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 35.97 Bn | 32.23 Bn | 1.97 Bn | - |
| 3 | Zoetis | 32.42 Bn | 30.48 Bn | 1.62 Bn | - |
| 4 | Takeda Pharmaceutical | 27.48 Bn | 23.42 Bn | 4.39 Bn | 32.85 Mn |
| 5 | United Therapeutics | 22.89 Bn | 20.73 Bn | 648.10 Mn | 41.80 Mn |
| 6 | RedHill Biopharma | 22.11 Bn | 22.11 Bn | - | - |
| 7 | Viatris | 20.44 Bn | 18.64 Bn | 1.16 Bn | - |
| 8 | Neurocrine Biosciences | 17.76 Bn | 16.44 Bn | 800.70 Mn | 28.10 Mn |
| 9 | Elanco Animal Health | 12.62 Bn | 12.19 Bn | 785.00 Mn | - |
| 10 | Organogenesis Holdings | 323.97 Mn | 231.87 Mn | 11.46 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2019 | 19,000.00 |
| Dec 31, 2018 | 5,000.00 |
| Sep 30, 2018 | 20,000.00 |
| Jun 30, 2018 | 20,000.00 |
| Mar 31, 2018 | 19,000.00 |
| Dec 31, 2017 | 28,000.00 |
| Sep 30, 2017 | 28,000.00 |
| Jun 30, 2017 | 35,000.00 |
| Mar 31, 2017 | 38,000.00 |